Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research Article: New Research, Disorders of the Nervous System

Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?

Dávid Pintér, Dániel Bereczki, András Ajtay, Ferenc Oberfrank, József Janszky and Norbert Kovács
eNeuro 16 April 2021, 8 (3) ENEURO.0452-20.2021; https://doi.org/10.1523/ENEURO.0452-20.2021
Dávid Pintér
1Department of Neurology, Medical School, University of Pécs, Pécs, Hungary 7623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dávid Pintér
Dániel Bereczki
2Department of Neurology, Medical School, Semmelweis University, Budapest, Hungary 1085
3Hungarian Academy of Sciences - Semmelweis University, Neuroepidemiology Research Group, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
András Ajtay
2Department of Neurology, Medical School, Semmelweis University, Budapest, Hungary 1085
3Hungarian Academy of Sciences - Semmelweis University, Neuroepidemiology Research Group, Budapest, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferenc Oberfrank
4Institute of Experimental Medicine, Budapest, Hungary 1083
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
József Janszky
1Department of Neurology, Medical School, University of Pécs, Pécs, Hungary 7623
5Hungarian Academy of Sciences - University of Pécs, Clinical Neuroscience Magnetic Resonance Research Group, Pécs, Hungary 7623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Kovács
1Department of Neurology, Medical School, University of Pécs, Pécs, Hungary 7623
5Hungarian Academy of Sciences - University of Pécs, Clinical Neuroscience Magnetic Resonance Research Group, Pécs, Hungary 7623
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0452-20.2021
PubMed 
33863783
Published By 
Society for Neuroscience
History 
  • Received October 21, 2020
  • Revision received February 19, 2021
  • Accepted March 2, 2021
  • Published online April 16, 2021.
Copyright & Usage 
Copyright © 2021 Pintér et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Dávid Pintér1,
  2. Dániel Bereczki2,3,
  3. András Ajtay2,3,
  4. Ferenc Oberfrank4,
  5. József Janszky1,5 and
  6. Norbert Kovács1,5
  1. 1Department of Neurology, Medical School, University of Pécs, Pécs, Hungary 7623
  2. 2Department of Neurology, Medical School, Semmelweis University, Budapest, Hungary 1085
  3. 3Hungarian Academy of Sciences - Semmelweis University, Neuroepidemiology Research Group, Budapest, Hungary
  4. 4Institute of Experimental Medicine, Budapest, Hungary 1083
  5. 5Hungarian Academy of Sciences - University of Pécs, Clinical Neuroscience Magnetic Resonance Research Group, Pécs, Hungary 7623
  1. Correspondence should be addressed to Dávid Pintér at david_pinter{at}outlook.com.
View Full Text

Author contributions

  1. Author contributions: D.P., D.B., A.A., F.O., J.J., and N.K. designed research; D.P. and N.K. performed research; D.P. and N.K. contributed unpublished reagents/analytic tools; D.P., D.B., A.A., F.O., J.J., and N.K. analyzed data; D.P. and N.K. wrote the paper.

Disclosures

  • The authors declare no competing financial interests.

  • This work was supported by the Hungarian Brain Research Program Grant 2017-1.2.1-NKP-2017-00002; National Research, Development and Innovation Office (NKFIH), Hungary, Grants EFOP-3.6.1-16-2016-00004, EFOP-3.6.2-16-2017-00008, SNN125143, and ÚNKP-17- 4 -I.- PTE-311. This work was also supported in part by the Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary, within the framework of the 5th thematic program of the University of Pécs, Hungary (20765/3/2018/FEKUSTRAT).

Funding

  • Hungarian Brain Research Program

    2017-1.2.1-NKP-2017-00002
  • NKFIH

    EFOP-3.6.1-16-2016-00004; EFOP-3.6.2-16-2017-00008; SNN125143
  • New National Excellence Program

    ÚNKP-17- 4 -I.- PTE-311
  • Higher Education Institutional Excellence Program of the Ministry of Human Capacities in Hungary

    20765/3/2018/FEKUSTRAT

Other Version

  • You are viewing the most recent version of this article.
  • previous version (April 16, 2021).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2025-06-24
to
E.g., 2025-06-24

Article usage: April 2021 to June 2025

AbstractFullPdf
Apr 2021231079
May 202112812863
Jun 20215425230
Jul 20211920222
Aug 20211520318
Sep 2021615976
Oct 20211013736
Nov 2021510231
Dec 2021511237
Total 20214731295392
Jan 2022411417
Feb 20221111133
Mar 202267219
Apr 202226418
May 202229625
Jun 202228112
Jul 202235712
Aug 202206311
Sep 202235212
Oct 202297224
Nov 202248222
Dec 202204814
Total 202246912219
Jan 202325413
Feb 202316317
Mar 20232597
Apr 20230745
May 20231696
Jun 202317311
Jul 202318120
Aug 202307720
Sep 202327316
Oct 202339611
Nov 20232707
Dec 2023210023
Total 202317889156
Jan 202448718
Feb 202418132
Mar 2024210525
Apr 202458334
May 202419936
Jun 202438532
Jul 202429026
Aug 202478210
Sep 202448420
Oct 202429424
Nov 202469420
Dec 2024510110
Total 2024421085287
Jan 2025410225
Feb 202519521
Mar 2025410923
Apr 202538814
May 202509523
Jun 202537111
Total 202515560117
Total59347411171
Back to top

In this issue

eneuro: 8 (3)
eNeuro
Vol. 8, Issue 3
May/June 2021
  • Table of Contents
  • Index by author
  • Ed Board (PDF)
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
Dávid Pintér, Dániel Bereczki, András Ajtay, Ferenc Oberfrank, József Janszky, Norbert Kovács
eNeuro 16 April 2021, 8 (3) ENEURO.0452-20.2021; DOI: 10.1523/ENEURO.0452-20.2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
Dávid Pintér, Dániel Bereczki, András Ajtay, Ferenc Oberfrank, József Janszky, Norbert Kovács
eNeuro 16 April 2021, 8 (3) ENEURO.0452-20.2021; DOI: 10.1523/ENEURO.0452-20.2021
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • trimetazidine
  • Parkinson’s disease
  • angina pectoris
  • European Medicines Agency
  • interrupted time series analysis

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Deletion of endocannabinoid synthesizing enzyme DAGLα in Pcp2-positive cerebellar Purkinje cells decreases depolarization-induced short-term synaptic plasticity, reduces social preference, and heightens anxiety
  • Release of extracellular matrix components after human traumatic brain injury
  • Action intentions reactivate representations of task-relevant cognitive cues
Show more Research Article: New Research

Disorders of the Nervous System

  • Release of extracellular matrix components after human traumatic brain injury
  • Gene variants related to primary familial brain calcification: perspectives from bibliometrics and meta-analysis
  • Expression of HDAC3-Y298H Point Mutant in Medial Habenula Cholinergic Neurons Has No Effect on Cocaine-Induced Behaviors
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.